Other captive investment companies
BIRK VENTURE AS
Revenue 2024
NOK 0
Operating profit
NOK −231,000
Equity
NOK 18.6m
Incorporated
2010
Share capital
NOK 200,000
Roles
Daglig lederHans Ivar Robinson
Regnskapsfører
Revisor
Styrets lederHans Ivar Robinson
VaramedlemEirin Guldsten Robinson
Auditor
Auditor at related companies
None of the 1 related companies use the same auditor.
| Company | Auditor | |
|---|---|---|
| BIRK INVESTMENT AS | DELOITTE AS | different |
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| BIRK INVESTMENT AS | 100.0% | 1000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| NEXTERA AS | Active | 15.0% | 647415.000000 |
| ZELLUNA ASA | Active | 5.6% | 1473507.000000 |
| APIM THERAPEUTICS AS | Active | 2.4% | 55451.000000 |
| ONCOINVENT ASA | Active | 0.1% | 396214.000000 |
| NYKODE THERAPEUTICS ASA | Active | 0.1% | 250000.000000 |
| ZELLUNA ASA | Active | 0.1% | 15000.000000 |
| ENDÚR ASA | Active | 0.0% | 7000.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.